Tempus AI Inc.

Tempus AI Inc. is a health technology company specializing in next-generation diagnostics and precision medicine powered by artificial intelligence. Founded in 2015 and headquartered in Chicago, Tempus leverages vast collections of clinical, molecular, and genomic data to deliver advanced diagnostic solutions across multiple medical fields, notably oncology, cardiology, and genomics. The company’s platforms and products utilize machine learning algorithms for genomic sequencing, molecular profiling, and clinical decision support, enabling healthcare providers to personalize treatments and address care gaps for patients. Tempus operates CAP/CLIA-certified laboratories, collaborates with leading pharmaceutical and biotech firms, and serves healthcare providers, researchers, and life sciences organizations globally. Its innovations include AI-driven diagnostic assays, FDA-cleared digital health devices, and data analytics tools that help accelerate research, improve patient outcomes, and support drug development. With a growing global presence and a multidisciplinary team, Tempus AI Inc. stands at the intersection of healthcare and technology, driving the adoption of data-centric solutions in modern medicine.